• Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

  • May 13 2024
  • Length: 42 mins
  • Podcast
Trillion Dollar Shot, Episode 1: Birth of a Blockbuster cover art

Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

Listen for free

View show details

  • Summary

  • Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen. In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction. But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap. Listen to Part 1 of “Trillion Dollar Shot” now. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show More Show Less
Business & Careers Politics & Government
Show More Show Less

What listeners say about Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.